LYRA - Lyra Therapeutics EPS misses by $0.12 misses on revenue November, 09 2021 04:36 PM Lyra Therapeutics Inc. Lyra Therapeutics (NASDAQ:LYRA): Q3 GAAP EPS of -$0.85 misses by $0.12. Revenue of $0.01M misses by $0.24M. Press Release For further details see: Lyra Therapeutics EPS misses by $0.12, misses on revenue